🟠 Allurion Technologies' (#NYSE: #ALUR) stock surged 350% following the announcement of a clinical study to optimize muscle mass during #GLP1 therapy using the Allurion Program.
#obesity #glp1 #weightloss #biotech @FDA $NVO $ALUR $SNY $SAN
#NYSE #ALUR #GLP1 #obesity #glp1 #weightloss #biotech #NVO #ALUR #SNY #SAN